Last reviewed 2026-04-20 · How we verify

CALCIFEDIOL ANHYDROUS

FDA-approved approved Small molecule Quality 1/100

CALCIFEDIOL ANHYDROUS is a drug. It is currently FDA-approved (first approved 1980).

At a glance

Generic name	CALCIFEDIOL ANHYDROUS
Modality	Small molecule
Phase	FDA-approved
First approval	1980

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CALCIFEDIOL ANHYDROUS CI brief — competitive landscape report
CALCIFEDIOL ANHYDROUS updates RSS · CI watch RSS

Frequently asked questions about CALCIFEDIOL ANHYDROUS

What is CALCIFEDIOL ANHYDROUS?

CALCIFEDIOL ANHYDROUS is a Small molecule drug.

When was CALCIFEDIOL ANHYDROUS approved?

CALCIFEDIOL ANHYDROUS was first approved on 1980.

What development phase is CALCIFEDIOL ANHYDROUS in?

CALCIFEDIOL ANHYDROUS is FDA-approved (marketed).

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing